ATG INDUCTION IS NOT A RISK FACTOR FOR DEVELOPING CMV DISEASE IN RECIPIENTS RECEIVING ORAL VALGANCICLOVIR PROPHYLAXIS
Ilham, M. A., Stephens, M., Glyn, E., Sinha, J., Asderakis, A.Volume:
90
Language:
english
Journal:
Transplantation Journal
DOI:
10.1097/00007890-201007272-01275
Date:
July, 2010
File:
PDF, 422 KB
english, 2010